How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30
FROMME, Erik K, EILERS, Kristine M, MORI, Motomi, HSIEH, Yi-Ching, BEER, Tomasz M
Published in Journal of clinical oncology (01.09.2004)
Published in Journal of clinical oncology (01.09.2004)
Get full text
Journal Article
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
Prins, Renee C., M.D, Rademacher, Brooks L., B.A, Mongoue-Tchokote, Solange, M.S, Alumkal, Joshi J., M.D, Graff, Julie N., M.D, Eilers, Kristine M., B.A, Beer, Tomasz M., M.D
Published in Urologic oncology (01.01.2012)
Published in Urologic oncology (01.01.2012)
Get full text
Journal Article
Cyclooxygenase‐2 (COX‐2) inhibition for prostate cancer chemoprevention: double‐blind randomised study of pre‐prostatectomy celecoxib or placebo
Flamiatos, Jason F., Beer, Tomasz M., Graff, Julie N., Eilers, Kristine M., Tian, Wei, Sekhon, Harman S., Garzotto, Mark
Published in BJU international (01.05.2017)
Published in BJU international (01.05.2017)
Get full text
Journal Article
Rationale for the development and current status of calcitriol in androgen-independent prostate cancer
BEER, Tomasz M, MYRTHUE, Anne, EILERS, Kristine M
Published in World journal of urology (01.02.2005)
Published in World journal of urology (01.02.2005)
Get full text
Journal Article
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
Beer, Tomasz M, Ryan, Charles, Alumkal, Joshi, Ryan, Christopher W, Sun, Janine, Eilers, Kristine M
Published in Anti-cancer drugs (01.04.2010)
Published in Anti-cancer drugs (01.04.2010)
Get more information
Journal Article
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making
Tao, Derrick L, Bailey, Shawna, Beer, Tomasz M, Foss, Erik, Beckett, Brooke, Fung, Alice, Foster, Bryan R, Guimaraes, Alexander, Cetnar, Jeremy P, Graff, Julie N, Eilers, Kristine M, Small, Eric J, Corless, Christopher L, Thomas, George V, Alumkal, Joshi J
Published in JCO precision oncology (01.01.2017)
Published in JCO precision oncology (01.01.2017)
Get more information
Journal Article
Docetaxel (Taxotere®) in the treatment of prostate cancer
Beer, Tomasz M, El-Geneidi, Mohammed, Eilers, Kristine M
Published in Expert review of anticancer therapy (01.06.2003)
Published in Expert review of anticancer therapy (01.06.2003)
Get full text
Journal Article
C-reactive Protein as a Prognostic Marker for Men With Androgen-independent Prostate Cancer : Results From the ASCENT Trial
BEER, Tomasz M, LALANI, Alshad S, CHI, Kim N, LEE, Stella, MORI, Motomi, EILERS, Kristine M, CURD, John G, HENNER, W. David, RYAN, Christopher W, VENNER, Peter, RUETHER, J. Dean
Published in Cancer (01.06.2008)
Published in Cancer (01.06.2008)
Get full text
Journal Article
Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer
Wagner, Matthew, Garzotto, Mark, Lemmon, Dianne, Eilers, Kristine M., Beer, Tomasz M.
Published in Urology (Ridgewood, N.J.) (01.04.2005)
Published in Urology (Ridgewood, N.J.) (01.04.2005)
Get full text
Journal Article
C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer
Beer, Tomasz M., Lalani, Alshad S., Lee, Stella, Mori, Motomi, Eilers, Kristine M., Curd, John G., Henner, W. David, Ryan, Christopher W., Venner, Peter, Ruether, J. Dean, Chi, Kim N.
Published in Cancer (01.06.2008)
Published in Cancer (01.06.2008)
Get full text
Journal Article